Cosa significa "Chiaro"?
L'animale non porta la mutazione. Non svilupperà la malattia e non lo trasmetterò.
Cane Acromatopsia di tipo 3 nel Bracco tedesco a pelo corto (PRAcd)
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers is essential for responsible breeding. This genetic screening identifies carriers of the PRAcd mutation, which causes progressive vision loss and color blindness in affected dogs. Early detection through DNA testing helps breeders prevent passing this hereditary condition to future generations. By using the PRAcd test, owners can ensure healthier litters and maintain the breed’s overall well-being. Regular testing supports informed breeding decisions and promotes the longevity of German Shorthaired Pointers. Protect your dog’s vision and contribute to breed health with the Achromatopsia Type 3 DNA test.
Abbreviazione: PRAcd
Mutazione analizzata: CNGB3 c.784G>A
Eredità: Autosomico recessivo
Acronimo
PRAcd
Frequenza osservata
Gravità clinica
Classificazione clinica
Malattie oftalmiche
Mutazione analizzata
CNGB3 c.784G>A
p.(D262N)
p.(D262N)
Modalità di ereditarietà
Autosomico recessivo
Riepilogo del test:
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers helps identify carriers and affected dogs. This inherited condition causes complete color blindness and vision problems. Early testing allows breeders to make informed decisions to reduce the risk of passing the disorder. By screening breeding dogs, the prevalence of PRAcd can be minimized in future generations. Responsible breeding ensures healthier dogs with better quality of life.
Disponibile dalla confezione: Basic
Questo test del DNA è incluso a partire dalla nostra confezione Basic — e fa anche parte dei pack Basic, Standard, Advanced, Complete.
Visualizza i pacchetti di test del DNA →Scegli il pack che meglio si adatta alla tua strategia di allevamento o di salute dei tuoi animali.
Understanding Achromatopsia Type 3 in German Shorthaired Pointers
Achromatopsia Type 3, also known as Progressive Retinal Atrophy with complete color blindness (PRAcd), is a hereditary condition that affects the vision of German Shorthaired Pointers. This genetic disorder results from mutations in specific genes that are crucial for the proper functioning of photoreceptor cells in the retina, leading to vision impairment over time.
Symptoms of Achromatopsia Type 3
Dogs affected by Achromatopsia Type 3 typically exhibit symptoms such as a lack of color vision, difficulty seeing in bright light, and potential night blindness. Owners may notice that their dogs have trouble navigating their environment, particularly in brightly lit areas, as their ability to perceive colors is significantly diminished.
Genetic Basis of the Condition
This condition is inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated for the dog to express the disease. Carriers, which have one normal and one mutated gene, do not show symptoms but can pass the condition to their offspring. Identifying carriers through DNA testing is essential for responsible breeding practices, as it helps prevent the propagation of the condition in future generations.
Impatto sulla qualità della vita
While Achromatopsia Type 3 can lead to significant visual impairment, many dogs adapt well to their condition. Owners can assist by providing a safe environment and ensuring that their pets are comfortable in low-light conditions or areas with bright lighting. Understanding the limitations of their dog's vision allows owners to make necessary adjustments to enhance their pet's quality of life.
Gestione e cura
Managing a dog with Achromatopsia Type 3 primarily involves environmental modifications rather than medical interventions. Owners should ensure that their living space is free from obstacles that could pose a danger, as affected dogs may not respond to visual cues in the same way as their sighted counterparts. Regular veterinary check-ups are also advised to monitor the dog's overall eye health and address any other potential issues that may arise.
Conclusione
Achromatopsia Type 3 in German Shorthaired Pointers is a serious genetic condition that affects visual perception. Understanding the symptoms, genetic basis, and management strategies is crucial for owners and breeders alike. Through responsible breeding and proper care, the impact of this condition on affected dogs can be alleviated, allowing them to lead fulfilling lives despite their visual challenges.
Razza riconosciuta per il test: Acromatopsia di tipo 3 nel Bracco tedesco a pelo corto (PRAcd)
- German Shorthaired Pointer
🧬 Interpretation of genotypes PRAcd
Genotipo
Stato
🟡 N/N
Non portatore: nessun rischio
🟡 N/PRAcd
Vettore: nessun rischio
❌ PRAcd/PRAcd
Interessato - A rischio
FAQ: comprendere l'interpretazione
Un “Portatore” è serio?
No. L'animale è generalmente sano ma può trasmettergli la mutazione prole.
Cosa succede se un animale è “affetto”?
Porta due copie mutate. I segni clinici sono attesi a seconda la malattia. Non dovrebbe essere allevato.
Perché ci sono differenze tra maschio/femmina?
Alcune malattie sono legate al sesso, quindi la loro espressione varia a seconda sesso dell'animale.
Predire la prole
N/N (non-portatore)
N/PRAcd (Vettore)
PRAcd/PRAcd (Ricercato)
Domande frequenti sul test del DNA
Cosa rileva questo test del DNA?
This DNA test detects the mutation associated with Achromatopsia Type 3 In German Shorthaired Pointer (PRAcd) in order to identify clear, carrier, or at-risk animals.
Perché testare un animale riproduttore?
Il test del DNA aiuta gli allevatori a pianificare accoppiamenti più sicuri e a ridurre il rischio di trasmettere la mutazione alla prole.
Qual è la modalità di ereditarietà di questo test?
La modalità di ereditarietà riportata per questo test è Autosomica Recessiva.
Quale mutazione viene analizzata in questo test?
This test analyses the mutation CNGB3 c.784G>A.
Un animale portatore è necessariamente affetto?
Non necessariamente. L'interpretazione dipende dal modello di ereditarietà e dal genotipo risultante.
Riferimenti
Sidjanin Duska J, Lowe Jennifer K, McElwee John L, Milne Bruce S, Phippen Taryn M, Sargan David R, Aguirre Gustavo D, Acland Gregory M, Ostrander Elaine A. Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet. 2002 Aug 1;11(16):1823-33. doi: 10.1093/hmg/11.16.1823.